分子标志物预测乳腺癌治疗疗效的研究进展  

Resent research about the molecular markers predicting the treatment efficacy of breast cnacer

作　　者：陈东波[1] 张科芝[1] 李俊[1] 

机构地区：[1]安徽医科大学第一附属医院肿瘤内科,安徽合肥230022

出　　处：《现代肿瘤医学》2012年第1期209-212,共4页Journal of Modern Oncology

摘　　要：乳腺癌是多种基因发生突变所导致的复杂疾病,尽早检出预后不佳的高危病人,及时给予合理的治疗,对于改善乳腺癌病人的预后有重要意义。本文通过综合国内外近年来发表的有代表性的有关乳腺癌分子标志物的文献资料,对乳腺癌预后分子标志物的研究进展进行总结,探讨这些分子标志物与乳腺癌治疗疗效及预后的关系。Breast cancer is is caused by mutations in multiple genes of complex diseases.Early detection of high-risk patients with poor prognosis,given reasonable and timely treatment,to improve for prognosis is significant important in breast cancer.In this paper,we review the comprehensive published representative literature at home and abroad in recent years about breast cancer of molecular markers,and give a summary for the progress of breast cancer research about prognostic molecular markers,and discuss the relationship between these molecular markers and breast cancer prognosis.

关 键 词：乳腺癌 分子标志物 预后 治疗疗效 

分 类 号：R737.9[医药卫生—肿瘤]